Healthcare

Smart Retinal Implants Market Restore vision with wireless bioelectronic prosthetics and AI-powered retinal technologies

Healthcare
/ /

The global smart retinal implants market is poised for robust expansion from 2025 to 2034, driven by increasing prevalence of vision-impairing diseases, rapid technological advancements in retinal prosthetics, and wider adoption of AI-enabled vision restoration systems. Valued at growing billions today, the market offers new hope for patients suffering from degenerative retinal conditions like age-related […]

RNA Editing for Neurodegenerative Diseases Market: Key Company Profiles

Companies, Healthcare
/ / ,

RNA Editing for Neurodegenerative Diseases Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Eli Lilly & Co. GSK Plc Korro Bio Moderna Inc. ProQR Therapeutics Roche Holding AG Shape Therapeutics Takeda Pharmaceutical Company Verve Therapeutics Wave Life Sciences Regeneron Pharmaceuticals Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. – San

The Leading AI-Driven Drug Discovery Platforms Market Companies: A Detailed Profile

Companies, Healthcare
/ / ,

AI-Driven Drug Discovery Platforms Market Companies Atomwise BenevolentAI Cloud Pharmaceuticals DeepMind (Alphabet) Exscientia Healx Insilico Medicine LabGenius Numerate Owkin Recursion Pharmaceuticals Relay Therapeutics Schrödinger Valo Health twoXa Download Sample Report Atomwise Company Name and Headquarters: Atomwise Inc., San Francisco, CA, USA Product Offerings: AtomNet® platform, an AI-powered drug discovery platform that uses deep convolutional neural networks to

Key Players in the Rare Musculoskeletal Disorder Treatments Market: A Comprehensive Company Profile

Companies, Healthcare
/ / ,

Rare Musculoskeletal Disorder Treatments Market Companies Astellas Amgen AstraZeneca BioMarin Pharmaceutical Eli Lilly Fujifilm/possible CDMOs (manufacturing partners) Ionis Pharmaceuticals Novartis Pfizer PTC Therapeutics Regenxbio Sarepta Therapeutics Sanofi Takeda Cytokinetics Download Sample Report Astellas Pharma Inc. Headquarters: Tokyo, Japan Product Offerings related to Rare Musculoskeletal Disorder Treatments: While Astellas is a major pharmaceutical company with a broad portfolio,

RNA Editing Therapies Market: Key Companies and Their Strategic Landscape Meta Title:

Companies, Healthcare
/ / ,

RNA Editing Therapies Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Catalent GSK Korro Bio Moderna ProQR Therapeutics Regenxbio Roche Shape Therapeutics Wave Life Sciences ADAPTABLE CDMO / specialized oligo CDMOs Smaller specialist startups & platform players Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. (San Diego, California, USA) Product

Rare Disease Small-Batch CDMO Market Accelerate orphan drug production with flexible manufacturing and tailored CDMO partnerships

Healthcare
/ /

The rare disease small-batch CDMO market is projected to experience significant growth through 2034, driven by the increasing prevalence of rare diseases and the rising approvals of orphan drugs. With an expected compound annual growth rate (CAGR) propelled by advancements in precision medicine and specialized manufacturing, this market is becoming a critical partner for biopharma

LNP CDMO Market Companies: In-Depth Profiles of Leading Players

Companies, Healthcare
/ / ,

LNP CDMO Market Companies Lonza Group WuXi AppTec Samsung Biologics Catalent Moderna Evonik Industries CordenPharma BioNTech Albemarle Corporation Kuehne + Nagel Northway Biotechpharma Cryoport, Inc. AMRI Pharmaron Genevant Sciences Miltenyi Biotec SynBioTech JHL Biotech Particle Sciences, Inc. Acell Technologie Download Sample Report Lonza Group Company Name and Headquarters: Lonza Group AG, Basel, Switzerland Product Offerings related

Biomarker Discovery Outsourcing Services Market: Detailed Company Profiles

Companies, Healthcare
/

Biomarker Discovery Outsourcing Services Market Companies Eurofins Scientific Charles River Laboratories ICON plc Labcorp Drug Development Thermo Fisher Scientific WuXi AppTec Syneos Health Q² Solutions (IQVIA & Quest Diagnostics JV) Bio-Rad Laboratories PPD Inc. (Thermo Fisher Scientific) SGS SA Evotec SE Creative Biolabs GenScript Biotech Corporation DiscoverX (Eurofins Discovery) Proteome Sciences plc Medpace Holdings, Inc.

Metabolomics Market Size to Attain USD 14.40 Billion by 2034

Healthcare
/ /

The global metabolomics market is poised for explosive growth, projected to surge from USD 4.31 billion in 2025 to an impressive USD 14.40 billion by 2034. This expansion reflects a robust CAGR of 14.34% over the forecast period, underscored by rising investments in precision medicine, biomarker discovery, and pharmaceutical R&D. North America currently leads the market, while Asia Pacific

Scroll to Top